Ligand validation:5E2N

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5E2N_EDO_A_305	69%	46%	0.1	0.916	0.73	1.25	-	-	0	0	100%	1
5E2N_EDO_A_306	50%	36%	0.098	0.846	0.88	1.51	-	-	0	0	100%	1
5E2N_EDO_A_303	42%	40%	0.21	0.935	0.58	1.63	-	-	3	0	100%	1
5E2N_EDO_B_305	36%	55%	0.107	0.796	0.63	0.94	-	-	0	0	100%	1
5E2N_EDO_A_304	26%	59%	0.163	0.809	0.66	0.75	-	-	2	0	100%	1
5E2N_EDO_B_303	24%	86%	0.191	0.824	0.53	0.14	-	-	0	0	100%	1
5E2N_EDO_B_304	15%	62%	0.227	0.796	0.56	0.75	-	-	2	0	100%	1
4QIZ_EDO_A_302	85%	75%	0.069	0.938	0.24	0.61	-	-	0	0	100%	1
4KNN_EDO_A_305	73%	24%	0.096	0.926	1.2	1.78	-	1	0	0	100%	1
4QJP_EDO_A_305	73%	85%	0.124	0.955	0.43	0.26	-	-	3	0	100%	1
5OHH_EDO_B_303	69%	47%	0.114	0.93	1.19	0.76	-	-	0	0	100%	1
4QSJ_EDO_B_307	67%	58%	0.099	0.908	0.66	0.8	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	79%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1
5MZ2_EDO_B_903	100%	84%	0.012	0.998	0.53	0.19	-	-	0	0	100%	1
5N9Z_EDO_K_202	100%	83%	0.017	0.998	0.39	0.34	-	-	0	0	100%	1
9O0J_EDO_A_303	100%	89%	0.017	0.996	0.25	0.33	-	-	0	0	100%	1
5EGE_EDO_A_505	100%	82%	0.019	0.997	0.5	0.26	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.